Baird Upgrades Cardinal Health to Outperform, Raises Price Target to $68

Baird analyst Eric Coldwell upgrades Cardinal Health (NYSE:CAH) from Neutral to Outperform and raises the price target from $54 to $68.

Benzinga · 02/07/2020 10:59

Baird analyst Eric Coldwell upgrades Cardinal Health (NYSE:CAH) from Neutral to Outperform and raises the price target from $54 to $68.